Nu Skin Enterprises (NYSE:NUS) Rating Lowered to Hold at Wall Street Zen

Nu Skin Enterprises (NYSE:NUS) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

A number of other research analysts have also recently issued reports on the stock. Zacks Research upgraded shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research note on Friday, January 30th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Thursday, January 22nd. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

Nu Skin Enterprises Stock Down 18.0%

Shares of NYSE NUS opened at $8.37 on Friday. The stock has a market cap of $408.09 million, a PE ratio of 2.62 and a beta of 1.01. The business has a fifty day moving average of $10.34 and a two-hundred day moving average of $10.65. Nu Skin Enterprises has a 52-week low of $5.32 and a 52-week high of $14.62. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.45 and a current ratio of 2.15.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 12th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.01). Nu Skin Enterprises had a return on equity of 8.21% and a net margin of 10.79%.The firm had revenue of $370.32 million during the quarter, compared to the consensus estimate of $382.70 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.800-1.200 EPS and its Q1 2026 guidance at 0.100-0.200 EPS. As a group, equities research analysts expect that Nu Skin Enterprises will post 1.05 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nu Skin Enterprises

Several large investors have recently made changes to their positions in the company. GAMMA Investing LLC boosted its stake in shares of Nu Skin Enterprises by 63.5% in the 3rd quarter. GAMMA Investing LLC now owns 3,036 shares of the company’s stock valued at $37,000 after purchasing an additional 1,179 shares during the last quarter. Atlantic Union Bankshares Corp acquired a new position in Nu Skin Enterprises in the second quarter valued at approximately $25,000. Wexford Capital LP bought a new position in Nu Skin Enterprises in the third quarter valued at approximately $40,000. Banque Cantonale Vaudoise bought a new position in Nu Skin Enterprises in the third quarter valued at approximately $57,000. Finally, Tower Research Capital LLC TRC grew its holdings in Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock worth $40,000 after acquiring an additional 2,614 shares during the period. Institutional investors and hedge funds own 82.84% of the company’s stock.

Trending Headlines about Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share (yield ~2.3%), payable Mar. 11 to holders of record Feb. 27 — supports income investors and signals capital-return discipline. Dividend Announcement
• Positive Sentiment: Management is pushing a strategic transformation (including India expansion) and commercial rollout of the Prysm iO device, targeting placement of 100,000 units in 2026 — a potential long-term revenue driver if adoption accelerates. Prysm iO / Strategy Article
• Neutral Sentiment: Company states Q4 and full-year results were within its guidance framework and highlighted >50% growth in 2025 earnings (adjusted), but the positive messaging contrasts with misses vs. external consensus — investors should weigh management framing against external estimates. Business Wire Release
• Neutral Sentiment: Coverage update from Stonegate reiterates reported Q4 numbers (revenue $370.3M; adjusted NI $14.5M; adj EPS $0.29) — a restatement of results rather than a new catalyst. Stonegate Coverage Update
• Negative Sentiment: Q4 results missed consensus: EPS $0.29 vs. $0.30 expected; revenue $370.3M vs. $382.7M expected — revenues fell 16.9% year-over-year with broad declines across key regions, which pressures near-term top-line recovery. Zacks Earnings Miss
• Negative Sentiment: Management cut Q1 and FY2026 guidance meaningfully below consensus — Q1 EPS $0.10–0.20 (street ~$0.29) and FY EPS $0.80–1.20 (street ~$1.42); revenue ranges likewise sit below expectations — the guidance shortfall is the primary driver of the market reaction. Guidance & Press Release
• Negative Sentiment: Analyst and media transcripts reiterate the miss and highlight deteriorating customer counts (paid affiliates down ~10%) and margin pressures; near-term fundamentals appear weaker than the market had modeled. Earnings Call Transcript

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.